25.1 C
London

InsightFinance UK

R1 and Palantir Technologies introduce R37: Transforming healthcare financial performance

R1 and Palantir Technologies launch R37, an AI lab transforming healthcare financial performance. Leveraging R1's extensive data and Palantir's AI, the lab aims to develop intelligent automation solutions for coding, billing, and denials management, with full deployment planned for H2 2025.

Investors Shift from cash ISAs to Stocks and Shares ISAs Amid planned reforms

Investors shift from Cash ISAs to Stocks and Shares ISAs, with new Cash ISA accounts down 7% over five years and Stocks and Shares ISA value up 37%. Chancellor Rachel Reeves plans ISA reforms, but Stocks and Shares ISAs remain popular despite delays.

Sheikh Tahnoon bin Zayed Tops Gulf Power List as UAE Doubling Down on Tech-Driven Sovereign Strategy

UAE's Sheikh Tahnoon bin Zayed leads Gulf Business's 2025 power list, representing a new era of state-sponsored tech investment and global capital influence

Recharge enters B2B with UK Giftcloud buyout

Recharge purchases Giftcloud from Groupon, expanding into B2B digital rewards business. Giftcloud is profitable with millions of transactions processed, which makes the UK Recharge's third-largest market. The purchase follows Recharge's €45M acquisition facility with ABN AMRO.

EY Slammed with Fine for Audit of Scottish Water Company

EY penalized £500,000 (reduced to £325,000) by the FRC for exaggerating the deadline for the ten-year audit term for Stirling Water Seafield Finance. This following a £6.5 million penalty for auditing Thomas Cook.

Scinai Immunotherapeutics into binding option agreement to acquire Pincell sr

Acquisition of Innovative Monoclonal Antibody Scinai Immunotherapeutics (Nasdaq: SCNI) inked a binding option agreement to purchase Italian biotech company Pincell srl, taking an interest in PC111, a monoclonal antibody in development for severe dermatological conditions like Pemphigus, Stevens-Johnson Syndrome (SJS),...
spot_img

latest articles